KINETICS OF INDUCTION OF TRANSPLANTATION TOLERANCE WITH A NONDEPLETING ANTI-Cd4 MONOCLONAL ANTIBODY AND DONOR-SPECIFIC TRANSFUSION BEFORE TRANSPLANTATION
- 15 June 1996
- journal article
- immunobiology
- Published by Wolters Kluwer Health in Transplantation
- Vol. 61 (11) , 1642-1647
- https://doi.org/10.1097/00007890-199606150-00016
Abstract
The combination of a depleting anti-Cd43monoclonal antibody (mAb) and a single donor-specific transfusion before transplantation has been shown to induce operational transplantation tolerance in the majority of cardiac allograft recipients in a mouse model. To examine a protocol which might be more clinically relevant, we have modified this tolerance-inducing protocol by substituting the depleting with a nondepleting anti-Cd4 mAb. We show that this form of pretreatment can also induce immunologic unresponsiveness in most recipients (C3H/He, H2k), provided a critical period of time, in this case 28 days, is allowed between pretreatment and transplantation of a fully mismatched heart graft (H2b). When only 1 or 2 weeks were allowed between pretreatment and transplantation, only slight graft prolongation was obtained when compared with recipients receiving anti-Cd4 mAb alone, at these time points. Maintenance of tolerance in this model was due, at least in part, to active mechanisms as immunologic unresponsiveness to donor antigens could be transferred to naive syngeneic mice by splenocytes from recipients bearing long-term functioning grafts. These findings suggest that a population of regulatory cells develop after pretreatment with nondepleting anti-Cd4 mAb and donor-specific transfusion, and that it takes at least 1 month for these cells to expand and effectively drive the recipient's immune system toward immunologic unresponsiveness.Keywords
This publication has 27 references indexed in Scilit:
- Treatment of myasthenia gravis with anti‐CD4 antibodyNeurology, 1994
- Phase 1 clinical trial of chimeric monoclonal anti‐CD4 antibody in multiple sclerosisNeurology, 1994
- In vivotreatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzeesClinical and Experimental Immunology, 1993
- THE EFFECT OF ANTI-L3T4 MONOCLONAL ANTIBODY TREATMENT ON FIRST-SET REJECTION OF MURINE CARDIAC ALLOGRAFTSTransplantation, 1987
- Islet Allograft Survival After a Single Course of Treatment of Recipient with Antibody to L3T4Science, 1987
- CD4 monoclonal antibody pairs for immunosuppression and tolerance inductionEuropean Journal of Immunology, 1987
- Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.The Journal of Experimental Medicine, 1985
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984
- ROLE OF THYMUS-DERIVED AND THYMUS-INDEPENDENT CELLS IN MURINE SKIN ALLOGRAFT REJECTIONTransplantation, 1982
- Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.The Journal of Experimental Medicine, 1981